Nasdaq: INBX
Inhibrx Biosciences insiders
The officers, directors and 10% owners of Inhibrx Biosciences, Inc. who hold the most stock, valued at the live INBX price.
$74.33
INBX today +$5.3M (+7.63%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 5
- Their INBX stock
- $266M
- Market value
- $1.10B
- Held by ranked insiders
- 24.3%
Insiders by value of INBX holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Inhibrx, Inc. | 10% owner | 1,157,926 | $86.1M | 7.84% | Corporate |
| 2 | Mark P. Lappe | Chief Executive Officer | 970,453 | $72.1M | 6.57% | 1938th |
| 3 | Jon Faiz Kayyem | Director | 754,203 | $56.1M | 5.11% | 2328th |
| 4 | Brendan P. Eckelman | Chief Scientific Officer | 473,888 | $35.2M | 3.21% | 3317th |
| 5 | Douglas G. Forsyth | Director | 227,064 | $16.9M | 1.54% | 5876th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Inhibrx Biosciences; see each profile for the filing.